DEF: Picard Medical Seeks Shareholder Approval for Key Corporate Changes

Picard Medical, Inc. is holding its annual stockholder meeting on July 17, 2026, to vote on critical proposals including a reverse stock split, the creation of Class B stock, director elections, and executive compensation.

Summary

• Picard Medical, Inc. is convening its Annual Meeting of Stockholders on July 17, 2026, entirely online.
• Key proposals include the election of four directors, advisory votes on executive compensation and its frequency, approval of a reverse stock split (1-for-15 to 1-for-50 ratio), and the creation of a new Class B common stock with 20 votes per share.
• The company is also seeking ratification of Malone Bailey LLP as its independent registered public accounting firm for 2026.
• The record date for determining eligible stockholders is June 26, 2026.
• The company is addressing potential non-compliance with NYSE American continued listing requirements, specifically related to stockholders' equity.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this filing as having a below-average sentiment due to the company's precarious position regarding NYSE American listing requirements and the potential dilutive effects of proposed corporate actions.

Positives

• The company is proactively seeking shareholder approval for significant corporate actions designed to improve its financial standing and market position.
• The online meeting format aims to increase stockholder participation.
• The proposed Class B common stock, while concentrating voting power, could offer strategic flexibility for future transactions.
• The board is seeking to maintain NYSE American listing compliance, which is crucial for liquidity and market access.

Negatives

• The company has received multiple notices of non-compliance with NYSE American listing standards regarding stockholders' equity, indicating potential financial distress.
• A reverse stock split is proposed to address these listing requirements, which can sometimes be perceived negatively by the market.
• The creation of Class B stock with enhanced voting rights could dilute the voting power of existing common stockholders and potentially lead to anti-takeover effects.
• Two named executive officers, Patrick NJ Schnegelsberg and Bernard Skaggs, have ceased their roles as CEO and CFO, respectively, as of June 2026.

Risks

• Failure to regain compliance with NYSE American listing requirements could lead to delisting, materially impairing stock liquidity, investor visibility, and access to capital markets.
• The reverse stock split may not achieve its objective of increasing the per-share trading price or improving marketability.
• The issuance of Class B common stock could concentrate voting power, potentially reducing the influence of existing common stockholders and discouraging favorable acquisition proposals.
• There is no assurance that the proposed reverse stock split or Class B stock designation will achieve their intended objectives.
• The company has a history of related party transactions, which could present ongoing governance or conflict of interest risks.

Future Outlook

The company is seeking shareholder approval for a reverse stock split and the creation of Class B common stock, which are intended to help it regain compliance with NYSE American listing standards and provide strategic flexibility. The success of these measures in improving market perception and financial standing is not guaranteed.

Management Comments

• "Your vote is very important!"
• "We urge you to read the enclosed proxy statement and vote as soon as possible via the Internet, by telephone or, if you receive a paper proxy card or voting instruction form in the mail, by mailing the completed proxy card or voting instruction form."
• "Thank you for your confidence and continued support."
• "The Board believes that having the ability to implement the Reverse Stock Split, if needed, will assist us in maintaining compliance with NYSE Americans listing standards by increasing our per-share trading price and improving the marketability of our Common Stock."
• "The Board believes that the structure of separating the roles of Chairman and CEO allows for better alignment of corporate governance with the interests of stockholders in protecting the Company's long-term enterprise value."

Industry Context

StockSavvy.ai notes that Picard Medical's proposed reverse stock split and creation of dual-class stock are common strategies employed by companies facing delisting risks or seeking to consolidate ownership control, particularly in the medical device sector where capital requirements and regulatory hurdles are significant.

Comparison to Industry Standards

• Companies in the medical device sector often face pressure to maintain minimum share prices to remain listed on major exchanges like NYSE American. A reverse stock split is a standard, albeit sometimes controversial, method to address this.
• The creation of a Class B stock with super-voting rights is a strategy seen in various industries, including technology and media, to allow founders or early investors to retain control despite a broader shareholder base and potential dilution from future equity raises.
• The company's reliance on related party financing, as detailed in the filing, is a common practice for early-stage companies but requires careful scrutiny for potential conflicts of interest compared to more diversified funding sources used by larger, established industry players.

Management Changes

Corporate Governance

Related Party Transactions

• The company has engaged in numerous loan transactions with entities affiliated with Richard Fang (Fang Family Fund, LLC, Fang Family Fund II, LLC, Fang Family Fund I, LLC) and Hunniwell (an entity affiliated with Richard Fang). These loans have varied interest rates and repayment terms, with many consolidated into convertible notes or secured notes.
• A $100,000 advance to Versa Capital Management, LLC, under an unsecured promissory note, was written off in 2025 as uncollectible.
• On November 12, 2024, Richard Fang donated a $7.0 million aggregated convertible note and accrued interest to Nexus Science Foundation Inc. and Another Dimension Foundation, which resulted in these foundations receiving shares at the IPO.
• The company determined it overpaid interest on certain Fang Family loans, resulting in a $134,712 receivable as of December 31, 2025.

Stakeholder Impact

• Shareholders: The proposed reverse stock split and Class B stock could impact voting power and stock liquidity. Advisory votes on compensation allow shareholders to voice opinions.
• Creditors/Lenders: The company's financial health and NYSE listing status are critical for its ability to service debt and secure future financing.
• Management and Employees: Changes in executive leadership and the potential impact of corporate actions on company performance and stock value are relevant.

Next Steps

• Stockholders to vote on the proposed resolutions at the Annual Meeting on July 17, 2026.
• If approved, the Board of Directors will determine the exact ratio and timing for the reverse stock split and the effective date for the Class B common stock designation.
• The company will file a Form 8-K with preliminary voting results within four business days after the Annual Meeting, and final results thereafter.
• The company must regain compliance with NYSE American listing requirements by November 8, 2027.

Key Dates

Recommendation

The company is at a critical juncture, facing potential delisting from NYSE American. While the proposed reverse stock split and Class B stock are intended to address these issues and provide strategic flexibility, their success is uncertain. The concentration of voting power with Class B stock could also be a concern for some investors. Given the significant risks and the speculative nature of the proposed solutions, a 'hold' recommendation is appropriate pending further clarity on the company's ability to regain compliance and execute its strategy.

Keywords

Picard Medical, DEF 14A, Proxy Statement, Annual Meeting, Reverse Stock Split, Class B Common Stock, Director Election, Executive Compensation, NYSE American, Listing Requirements, Corporate Governance